Pennant Group (PNTG) - Rasio rega marang prakiraan pendapatan

Logo perusahaan publik pennantgroup.com (PNTG)

The Pennant Group, Inc. (PNTG) management acts as an active serial consolidator, acquiring local agencies to accelerate growth. The expected revenue multiple visualizes the results of this expansion, where the indicator value is 0.70. The strategy is based on consolidating hospices and care services against the backdrop of an aging nation. The company generates revenue from Medicare/Medicaid government programs and insurance payments for medical rehabilitation.

The Pennant Group - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep PNTG (periode 04.07.2022 - 15.11.2026)

The Pennant Group, Inc. - rincian analitis lan metrik utama (PNTG)

- rega saham lan target rega konsensus:
Analisis fundamental perusahaan:PNTG (The Pennant Group, Inc.)
Produk asli The Pennant Group Corp

Forward P/S determines the market value of a business relative to expected sales volume, measuring the premium for potential growth. For The Pennant Group, Inc. (PNTG), this ratio reflects the monetization of ESG standard implementation and the optimization of bio-waste utilization in clinics. By analyzing the forward P/S, an investor can identify whether the asset is overbought or possesses hidden growth potential. The indicator's trend confirms fundamental stability and the quality of capital management.

Analisis pesaing The Pennant Group, Inc.

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|PGNY - Rasio rega marang prakiraan pendapatan|ARDT - Multiplikator Forward P/S|SEM: Multiplikator Forward P/S|astranahealth.com (ASTH) - Multiplikator Forward P/S|MD (mednax.com) - Multiplikator Forward P/S|Multiplikator Forward P/S usph.com|Rasio rega marang prakiraan pendapatan Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Rega forward marang dodolan|Multiplikator Forward P/S AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|EOLS - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan MDWD|Rasio rega marang prakiraan pendapatan biote Corp.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep thejoint.com JYNT|Multiplikator Forward P/S DCGO|Multiplikator forward rega marang pendapatan P3 Health PIII|Multiplikator Forward P/S GANX (Gain Therapeutics Inc.)|Multiplikator Forward P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator Forward P/S|CLGN: Rasio rega marang prakiraan pendapatan|Cuprina Holdings (Cayman) Ltd. (CUPR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Concord Medical|AMS (American Shared Hospital Services Inc) - Multiplikator Forward P/S|MEDIROM Corp (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ALBT|Rasio kapitalisasi marang dodolan sing dikarepake DIH Holding|Multiplikator Forward P/S XAGE (carmellcosmetics.com)|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)